4.7 Article

Bilateral Contrast-enhanced Dual-Energy Digital Mammography: Feasibility and Comparison with Conventional Digital Mammography and MR Imaging in Women with Known Breast Carcinoma

Journal

RADIOLOGY
Volume 266, Issue 3, Pages 743-751

Publisher

RADIOLOGICAL SOC NORTH AMERICA (RSNA)
DOI: 10.1148/radiol.12121084

Keywords

-

Ask authors/readers for more resources

Purpose: To determine feasibility of performing bilateral dual-energy (DE) contrast agent-enhanced (CE) digital mammography and to evaluate its performance compared with conventional digital mammography and breast magnetic resonance (MR) imaging in women with known breast cancer. Materials and Methods: This study was approved by the institutional review board and was HIPAA compliant. Written informed consent was obtained. Patient accrual began in March 2010 and ended in August 2011. Mean patient age was 49.6 years (range, 25-74 years). Feasibility was evaluated in 10 women with newly diagnosed breast cancer who were injected with 1.5 mL per kilogram of body weight of iohexol and imaged between 2.5 and 10 minutes after injection. Once feasibility was confirmed, 52 women with newly diagnosed cancer who had undergone breast MR imaging gave consent to undergo DE CE digital mammography. Positive findings were confirmed with pathologic findings. Results: Feasibility was confirmed with no adverse events. Visualization of tumor enhancement was independent of timing after contrast agent injection for up to 10 minutes. MR imaging and DE CE digital mammography both depicted 50 (96%) of 52 index tumors; conventional mammography depicted 42 (81%). Lesions depicted by using DE CE digital mammography ranged from 4 to 67 mm in size (median, 17 mm). DE CE digital mammography depicted 14 (56%) of 25 additional ipsilateral cancers compared with 22 (88%) of 25 for MR imaging. There were two false-positive findings with DE CE digital mammography and 13 false-positive findings with MR imaging. There was one contralateral cancer, which was not evident with either modality. Conclusion: Bilateral DE CE digital mammography was feasible and easily accomplished. It was used to detect known primary tumors at a rate comparable to that of MR imaging and higher than that of conventional digital mammography. DE CE digital mammography had a lower sensitivity for detecting additional ipsilateral cancers than did MR imaging, but the specificity was higher. (C) RSNA, 2012

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Radiology, Nuclear Medicine & Medical Imaging

Contrast-enhanced Mammography: State of the Art

Maxine S. Jochelson, Marc B. Lobbes

Summary: Contrast-enhanced mammography (CEM) is a promising alternative to contrast-enhanced breast MRI, offering improved accuracy in vascular imaging while reducing examination costs. It has shown positive outcomes in diagnosing breast lesions and screening, as well as in preoperative staging and monitoring response to chemotherapy in breast cancer patients. Early results also indicate potential benefits in screening high-risk women for breast cancer, although there are slight risks and increased radiation dose associated with CEM.

RADIOLOGY (2021)

Article Medicine, General & Internal

Radiomics and Machine Learning with Multiparametric Breast MRI for Improved Diagnostic Accuracy in Breast Cancer Diagnosis

Isaac Daimiel Naranjo, Peter Gibbs, Jeffrey S. Reiner, Roberto Lo Gullo, Caleb Sooknanan, Sunitha B. Thakur, Maxine S. Jochelson, Varadan Sevilimedu, Elizabeth A. Morris, Pascal A. T. Baltzer, Thomas H. Helbich, Katja Pinker

Summary: This multicenter retrospective study evaluated the combined radiomics analysis and machine learning of dynamic contrast-enhanced (DCE) and diffusion-weighted imaging (DWI) for improved breast cancer detection. The multiparametric MRI model combining DCE and DWI features showed the best diagnostic accuracy, reducing unnecessary benign breast biopsies.

DIAGNOSTICS (2021)

Article Oncology

Assessing PD-L1 Expression Status Using Radiomic Features from Contrast-Enhanced Breast MRI in Breast Cancer Patients: Initial Results

Roberto Lo Gullo, Hannah Wen, Jeffrey S. Reiner, Raza Hoda, Varadan Sevilimedu, Danny F. Martinez, Sunitha B. Thakur, Maxine S. Jochelson, Peter Gibbs, Katja Pinker

Summary: This study is the first to assess the use of radiomics coupled with machine learning from MRI-derived features to predict PD-L1 expression status in triple negative breast cancers and compare it with qualitative assessment by radiologists. The results show that this approach is promising for predicting PD-L1 status and selecting patients for anti-PD-1/PD-L1 treatment. It could also be used to monitor PD-L1 expression without the need for repeated biopsies.

CANCERS (2021)

Review Oncology

To Look or Not to Look? Yes to Nodal Ultrasound!

Gaiane M. Rauch, Henry M. Kuerer, Maxine S. Jochelson

Summary: Knowledge of axillary nodal status is crucial for staging and treatment planning in breast cancer patients. Axillary ultrasound is a valuable tool for assessing nodal status and guiding treatment decisions. Recent advancements in surgical management and neoadjuvant therapy for breast cancer have raised questions about the utility of axillary ultrasound, but ongoing trials continue to assess its role in improving patient outcomes by providing more personalized treatment approaches.

JOURNAL OF BREAST IMAGING (2021)

Review Oncology

To Look or Not to Look? Axillary Imaging: Less May Be More

Victoria L. Mango, Melissa Pilewskie, Maxine S. Jochelson

Summary: Axillary lymph node status is crucial in predicting outcomes for breast cancer patients and requires multidisciplinary collaboration. While imaging plays an important role in assessing the axilla, it is essential to judiciously decide when to perform axillary ultrasound and/or image-guided biopsy to avoid unnecessary procedures.

JOURNAL OF BREAST IMAGING (2021)

Article Oncology

Breast Lesion Classification with Multiparametric Breast MRI Using Radiomics and Machine Learning: A Comparison with Radiologists' Performance

Isaac Daimiel Naranjo, Peter Gibbs, Jeffrey S. Reiner, Roberto Lo Gullo, Sunitha B. Thakur, Maxine S. Jochelson, Nikita Thakur, Pascal A. T. Baltzer, Thomas H. Helbich, Katja Pinker

Summary: Breast contrast-enhanced MRI is highly sensitive for breast cancer detection, but has low specificity. Multiparametric MRI with diffusion-weighted imaging can improve the accuracy of breast lesion discrimination. Our study demonstrates the potential of multiparametric radiomics and machine learning in assisting lesion differentiation on breast MRI in clinical practice. AI algorithms can support less experienced readers and improve the accuracy of breast lesion discrimination.

CANCERS (2022)

Review Radiology, Nuclear Medicine & Medical Imaging

Standalone AI for Breast Cancer Detection at Screening Digital Mammography and Digital Breast Tomosynthesis:A Systematic Review and Meta-Analysis

Jung Hyun Yoon, Fredrik Strand, Pascal A. T. Baltzer, Emily F. Conant, Fiona J. Gilbert, Constance D. Lehman, Elizabeth A. Morris, Lisa A. Mullen, Robert M. Nishikawa, Nisha Sharma, Ilse Vejborg, Linda Moy, Ritse M. Mann

Summary: This study evaluated the performance of artificial intelligence (AI) in the interpretation of digital mammography and digital breast tomosynthesis (DBT). The results showed that standalone AI performed as well as or better than radiologists in digital mammography, but there were insufficient studies to assess its performance in DBT interpretation.

RADIOLOGY (2023)

Article Economics

Economic evaluation of supplemental breast cancer screening modalities to mammography or digital breast tomosynthesis in women with heterogeneously and extremely dense breasts and average or intermediate breast cancer risk in US healthcare

Michael Blankenburg, Irene Sanchez-Collado, Busayo Oladimeji Soyemi, Oerjan akerborg, Amrit Caleyachetty, James Harris, Elizabeth Morris, Gillian Newstead, Franziska Lobig

Summary: This study evaluated the cost-effectiveness of supplemental breast imaging modalities for women with dense breasts and intermediate or high risk of breast cancer in the USA. The results showed that all supplemental imaging modalities were cost-effective, with ultrasound and abbreviated MRI having the lowest incremental cost-effectiveness ratios. MRI and CEM demonstrated the best clinical outcomes compared to standard imaging modalities.

JOURNAL OF MEDICAL ECONOMICS (2023)

Article Multidisciplinary Sciences

Biomineralogical signatures of breast microcalcifications

Jennie A. M. R. Kunitake, Daniel Sudilovsky, Lynn M. Johnson, Hyun-Chae Loh, Siyoung Choi, Patrick G. Morris, Maxine S. Jochelson, Neil M. Iyengar, Monica Morrow, Admir Masic, Claudia Fischbach, Lara A. Estroff

Summary: Microcalcifications, primarily biogenic apatite, are important indicators in mammography for cancerous and benign breast pathologies. This study investigates the heterogeneity of 93 calcifications from 21 breast cancer patients using an omics-inspired approach, revealing physiological clusters, intratumor heterogeneity in carbonate content, enhanced trace metals in malignant-localized calcifications, and lower lipid-to-protein ratio in patients with poor composite outcome, suggesting potential clinical value in expanding research on calcification diagnostic metrics.

SCIENCE ADVANCES (2023)

Editorial Material Radiology, Nuclear Medicine & Medical Imaging

Contrast mammography-a promising tool for the pre-operative evaluation of lobular breast cancer

Maxine S. Jochelson, Rita A. Mukhtar

EUROPEAN JOURNAL OF RADIOLOGY (2023)

Article Oncology

High-Temporal/High-Spatial Resolution Breast Magnetic Resonance Imaging Improves Diagnostic Accuracy Compared With Standard Breast Magnetic Resonance Imaging in Patients With High Background Parenchymal Enhancement

Sarah Eskreis-Winkler, Janice S. Sung, Linden Dixon, Natasha Monga, Ragni Jindal, Amber Simmons, Sunitha Thakur, Varadan Sevilimedu, Elizabeth Sutton, Christopher Comstock, Kimberly Feigin, Katja Pinker

Summary: This study compared the diagnostic performance of breast magnetic resonance imaging (MRI) using a standard high-spatial resolution protocol to a simultaneous high-temporal/high-spatial resolution (HTHS) protocol in women with high levels of background parenchymal enhancement (BPE). The results showed that the HTHS protocol improved the diagnostic performance of breast MRI, leading to a higher cancer detection rate and positive predictive value of biopsy, as well as a decrease in unnecessary biopsies.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Association of Breast Cancer Odds with Background Parenchymal Enhancement Quantified Using a Fully Automated Method at MRI: The IMAGINE Study

Gordon P. Watt, Snekha Thakran, Janice S. Sung, Maxine S. Jochelson, Marc B. I. Lobbes, Susan P. Weinstein, Angela R. Bradbury, Saundra S. Buys, Elizabeth A. Morris, Aditya Apte, Prusha Patel, Meghan Woods, Xiaolin Liang, Malcolm C. Pike, Despina Kontos, Jonine L. Bernstein

Summary: This study found that objectively measured BPE at breast MRI is associated with increased odds of breast cancer. High BPE extent is associated with a higher risk of breast cancer, and this association is consistent in both premenopausal and postmenopausal women.

RADIOLOGY (2023)

Article Health Care Sciences & Services

Developing a Technology Acceptability and Usage Survey (TAUS) for mHealth Intervention Planning and Evaluation in Nigeria: Pilot Study

Kathleen A. Lynch, Thomas M. Atkinson, Adeleye D. Omisore, Olusola Famurewa, Olalekan Olasehinde, Oluwole Odujoko, Olusegun Alatise, Adedeji Egberongbe, T. Peter Kingham, Elizabeth A. Morris, Elizabeth Sutton

Summary: This article describes a pilot study aimed at developing a Technology Acceptability and Usage Survey (TAUS) that is suitable for low- and middle-income country (LMIC) clinical settings. Through a literature review and expert review, a final measure consisting of 18 items was established, which proved to be valuable in guiding the implementation of mHealth interventions.

JMIR FORMATIVE RESEARCH (2022)

No Data Available